Swiss Oncology in Motion Module Urothelial Carcinoma CME continuing education Education Oncology Partner Content RX Urology View Post
View Post This content is machine translated Swiss Oncology in Motion Special “GENETIC INSTABILITY” In the special “GENETIC INSTABILITY” of Swiss Oncology in Motion, Prof. Dr. med. Viola Heinzelmann-Schwarz (University Hospital Basel), Prof. Dr. med. Jens Huober (Canton Hospital St. Gallen), PD Dr. med. Aurelius Omlin (OnkoZentrum Zürich), Prof. Dr. med. Dr. phil. Andreas Wicki (University Hospital Zurich) and Prof. Dr. med. Wolfram Jochum (Cantonal Hospital St. Gallen) discussed the role of genetic instability in various tumor types, in particular ovarian and endometrial carcinomas, breast carcionoma, GI tumors, and prostate, urothelial, and renal cell carcinomas, and how it influences treatment options. The discussion will be led by Prof. em. Richard Herrmann, MD, Basel, moderated. CME-Test
View Post This content is machine translated Swiss Oncology in Motion Special immunotherapy for cancer Immunotherapy is about to revolutionize cancer treatment. That’s why it’s important to stay up to date in this rapidly changing field. With the current new Special Immunotherapies in Cancer from Swiss Oncology in Motion, you will receive a brief overview of the basics from Sacha Rothschild, MD. Afterwards, under the moderation of Prof. em. Richard Herrmann PD Dr. med. Richard Cathomas, Kantonsspital Chur, Dr. med. Ioannis Metaxas, Kantonsspital Thurgau, Dr. med. Berna Özdemir, Inselspital Bern and PD Dr. med. Dr. phil. Sacha Rothschild, University Hospital Basel the most relevant aspects for clinic and practice. CME-Test
View Post This content is machine translated Online training Swiss Oncology in Motion Ovarian Cancer Module Around 600 women are affected by ovarian cancer in Switzerland every year. Due to the non-specific symptoms, the disease is often only diagnosed at an advanced stage and most patients suffer a relapse. The Ovarian Cancer module of Swiss Oncology in Motion includes articles by Prof. em. Dr. med. Richard Herrmann moderated presentations by Dr. med. Dr. sc. nat. Anita Wolfer (Lausanne), Prof. Andreas Günthert (Lucerne) and PD Marcus Vetter (Basel). The ovarian cancer module was updated in June 2022.
View Post This content is machine translated Online training Swiss Oncology in Motion Pancreatic Cancer Module The Pancreatic Cancer module of Swiss Oncology in Motion includes articles by Prof. em. Richard Herrmann, MD, moderated presentations by Raphaël Delaloye, MD, (Department of Oncology, University Hospital Basel), PD Sara De Dosso, MD, (Instituto Oncologico della Svizzera Italiana (IOSI), Bellinzona Universita della Svizzera Italiana (USI), Lugano), and Alexander Siebenhüner, MD, (Oncology and Hematology, Kantonsspital Schaffhausen). You can get an overview of key information on incidence and epidemiology, pathology and molecular biology (including common genetic mutations), as well as diagnosis and available treatment options and corresponding study data. CME-Test
View Post This content is machine translated Acute myeloid leukemia (AML) “A new standard of care for elderly and fragile patients” A BCL-2 inhibitor is convincing in new studies in the first-line treatment of AML patients who are not suitable for intensive chemotherapy [1]. Hematologists Dr. Georgios Georgiou and Prof. Photis Beris assess the impact of these new data on the existing therapeutic landscape.
View Post This content is machine translated Online training Swiss Oncology in Motion Acute Myeloid Leukemia Module After many years without noticeable therapeutic progress, a number of new treatment options for acute myeloid leukemia have recently become available that could improve the situation for those affected. Prof. em. Richard Herrmann, MD, speaks in the Acute Myeloid Leukemia module of Swiss Oncology in Motion with Prof. Mario Bargetzi, MD (Kantonsspital Aarau), Rouven Müller, MD (USZ Zurich) and Prof. Georg Stüssi, MD (IOSI, Ticino). CME-Test
View Post This content is machine translated Online training Swiss Oncology in Motion Module Prostate Cancer Treatment options for prostate cancer have evolved rapidly over the past two years, with advances across the spectrum of disease stages. Prof. em. Richard Herrmann, MD, speaks with Tobias Gross, MD (Inselspital Bern), Marie-Laure Amram, MD (Hirslanden) and Richard Cathomas, MD (Kantonsspital Graubünden) in the Swiss Oncology in Motion module on prostate cancer. CME-Test
View Post This content is machine translated Online training Swiss Oncology in Motion Module: COVID-19 and oncology patients There are no evidence-based recommendations for the management of tumor patients in corona crisis. The procedure is based worldwide on rational considerations and analogies. Through careful observations and exchange of information, we can learn every day and gradually optimize this approach. The expert panel* “COVID-19 and oncological patients” is intended to inform you about the current state of knowledge and to give you ideas for your own professional everyday life. CME-Test
View Post This content is machine translated Editorial Swiss Oncology in Motion: Video-based online training courses Educational films in various modules for medical oncologists, hematologists and oncology specialists. Oncology is on the move – research is advancing rapidly and new insights into biology and therapy are constantly being gained. On the Swiss Oncology in Motion platform, relevant oncology topics are presented in modules with three expert presentations each as video training including CME questions.
View Post This content is machine translated Online training Swiss Oncology in Motion Chronic Lymphocytic Leukemia Module The Chronic Lymphocytic Leukemia module of Swiss Oncology in Motion includes articles by Prof. em. Richard Herrmann, MD, moderated presentations by PD Jeroen S. Goede, MD, Head of Hematology (Head of the Center for Lymphomas and Leukemias), Michael Gregor, MD, Head of Hematology (Lucerne Cantonal Hospital) and Prof. Thorsten Zenz, MD, Head of the Center for Hematology and Oncology (University Hospital Zurich).
